FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 151 filers reported holding FATE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,500,697 | -61.6% | 1,651,272 | -13.9% | 0.01% | -60.9% |
| Q2 2023 | $9,127,514 | -11.2% | 1,917,545 | +6.3% | 0.02% | -20.7% |
| Q1 2023 | $10,277,573 | -32.3% | 1,803,083 | +19.9% | 0.03% | -39.6% |
| Q4 2022 | $15,172,838 | +258.1% | 1,503,750 | +695.4% | 0.05% | +242.9% |
| Q3 2022 | $4,237,000 | +392.7% | 189,067 | +1186.2% | 0.01% | +600.0% |
| Q4 2021 | $860,000 | -95.2% | 14,700 | -95.1% | 0.00% | -95.0% |
| Q3 2021 | $17,754,000 | -30.2% | 299,542 | +2.2% | 0.04% | -31.0% |
| Q2 2021 | $25,436,000 | -53.2% | 293,075 | -55.6% | 0.06% | -58.9% |
| Q1 2021 | $54,383,000 | +85.5% | 659,583 | +104.6% | 0.14% | +67.9% |
| Q4 2020 | $29,311,000 | +98.8% | 322,342 | -12.6% | 0.08% | +61.5% |
| Q3 2020 | $14,746,000 | +98.1% | 368,924 | +70.0% | 0.05% | +40.5% |
| Q2 2020 | $7,444,000 | +1337.1% | 216,963 | +719.3% | 0.04% | +1750.0% |
| Q4 2019 | $518,000 | -51.8% | 26,482 | -61.7% | 0.00% | -50.0% |
| Q3 2019 | $1,075,000 | -65.5% | 69,221 | -61.0% | 0.00% | -60.0% |
| Q1 2019 | $3,117,000 | -25.9% | 177,404 | -45.9% | 0.01% | -37.5% |
| Q4 2018 | $4,207,000 | -44.1% | 327,875 | -29.1% | 0.02% | -23.8% |
| Q3 2018 | $7,532,000 | +284.3% | 462,369 | +167.5% | 0.02% | +250.0% |
| Q2 2018 | $1,960,000 | +121.5% | 172,845 | +90.6% | 0.01% | +100.0% |
| Q1 2018 | $885,000 | -15.1% | 90,704 | -46.8% | 0.00% | 0.0% |
| Q4 2017 | $1,043,000 | +848.2% | 170,636 | +179.1% | 0.00% | +200.0% |
| Q1 2016 | $110,000 | +64.2% | 61,141 | +206.5% | 0.00% | – |
| Q4 2015 | $67,000 | +1.5% | 19,946 | +62.2% | 0.00% | – |
| Q3 2015 | $66,000 | – | 12,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $83,733,000 | 21.39% |
| Redmile Group, LLC | 12,957,222 | $321,080,000 | 12.26% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $25,703,000 | 5.81% |
| Casdin Capital, LLC | 2,100,000 | $52,038,000 | 4.40% |
| Ally Bridge Group (NY) LLC | 181,500 | $4,498,000 | 4.10% |
| DAFNA Capital Management LLC | 550,940 | $13,652,000 | 3.72% |
| Artal Group S.A. | 2,600,000 | $64,428,000 | 3.44% |
| Deep Track Capital, LP | 2,018,005 | $50,006,000 | 3.29% |
| HighVista Strategies LLC | 118,778 | $2,943,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,917 | $158,000,000 | 1.65% |